Carbon Medical Technologies, Inc.
Carbon Medical Technologies, Inc. (FKA Advanced UroScience, Inc.) was formed in 1994 for the purpose of developing permanent human implantable products utilizing pyrolytic carbon. Carbon is a naturally occurring element in the human body. As a result, pyrolytic carbon is not recognized by the human body as foreign, thus rendering it ideal as a permanent implant material. Carbon Medical Technologies (CMT) operates a fully functional pyrolytic carbon-coating facility, one of five known to exist in the world. We seek to develop best-in-class products that improve lives throughout the world. We care about patients, customers, and each other. The team at Carbon Medical Technologies, Inc. is driven to continuously improve and constantly learn as markets evolve, techniques change, and technology advances. Our workplace promotes creativity and collaboration in pursuit of company growth and personal development.
The CMT business model is to design, develop and manufacture pyrolytic carbon-based implants, successfully navigate the regulatory process and bring the products to market. This could happen through divesting or licensing products for commercialization, entering into a distribution agreement, or direct sales.